Effects of transforming growth factor beta-activated kinase 1 (TAK1) on apoptosis of HK-2 cells in the high glucose environment

References

• Heerspink HJL, Parving HH, Andress DL, et al. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Lancet. 2019;393(10184):1937–1947.
   PubMed Web of Science ®Google Scholar
• Kumar Pasupulati A, Chitra PS, Reddy GB. Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy. Biomol Concepts. 2016;7(5–6):293–309.
   PubMedGoogle Scholar
• Volpe CMO, Villar-Delfino PH, Dos Anjos PMF, et al. Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death Dis. 2018;9(2):119.
   PubMed Web of Science ®Google Scholar
• Priante G, Gianesello L, Ceol M, et al. Cell Death in the Kidney. Int J Mol Sci. 2019;20(14):3598.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Lee DY, Mariappan MM, et al. Hydrogen sulfide inhibits high glucose-induced NADPH oxidase 4 expression and matrix increase by recruiting inducible nitric oxide synthase in kidney proximal tubular epithelial cells. J Biol Chem. 2017;292(14):5665–5675.
   PubMed Web of Science ®Google Scholar
• Ajibade AA, Wang HY, Wang RF. Cell type-specific function of TAK1 in innate immune signaling. Trends Immunol. 2013;34(7):307–316.
   PubMed Web of Science ®Google Scholar
• Sakurai H. Targeting of TAK1 in inflammatory disorders and cancer. Trends Pharmacol Sci. 2012;33(10):522–530.
   PubMed Web of Science ®Google Scholar
• Wang Y, Mao Y, Zhang X, et al. TAK1 may promote the development of diabetic nephropathy by reducing the stability of SnoN protein. Life Sci. 2019;228:1–10.
   PubMed Web of Science ®Google Scholar
• Miyajima A, Chen J, Lawrence C, et al. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int. 2000;58(6):2301–2313.
   PubMed Web of Science ®Google Scholar
• Dai C, Yang J, Liu Y. Transforming growth factor-beta1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling. J Biol Chem. 2003;278(14):12537–12545.
   PubMed Web of Science ®Google Scholar
• Jiang M, Zhang H, Zhai L, et al. ALA/LA ameliorates glucose toxicity on HK-2 cells by attenuating oxidative stress and apoptosis through the ROS/p38/TGF-β(1) pathway. Lipids Health Dis. 2017;16(1):216.
   PubMedGoogle Scholar
• Wu J, Powell F, Larsen NA, et al. Mechanism and In Vitro Pharmacology of TAK1 Inhibition by (5Z)-7-Oxozeaenol. ACS Chem Biol. 2013;8(3):643–650.
   PubMed Web of Science ®Google Scholar
• Xia A, Li Y, Li N, et al. Roles of MAPKAPK-2 and HSP27 in the reduction of renal ischemia-reperfusion injury by ischemic postconditioning in rats. Int Urol Nephrol. 2014;46(7):1455–1464.
   PubMed Web of Science ®Google Scholar
• Yu R, Zhang Y, Lu Z, et al. Long-chain non-coding RNA UCA1 inhibits renal tubular epithelial cell apoptosis by targeting microRNA-206 in diabetic nephropathy. Arch Physiol Biochem. 2019;1–9. 10.1080/13813455.2019.1673431.
   Web of Science ®Google Scholar
• Guo Y, Xie X, Zhao Y, et al. Calcitriol attenuates renal tubular epithelial cells apoptosis via inhibiting p38MAPK signaling in diabetic nephropathy. Acta Diabetol. 2020;57(11):1327–1335.
   PubMed Web of Science ®Google Scholar
• Rochette L, Zeller M, Cottin Y, et al. Diabetes, oxidative stress and therapeutic strategies. Biochim Biophys Acta. 2014;1840(9):2709–2729.
   PubMed Web of Science ®Google Scholar
• Matsuda M, Shimomura I. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes Res Clin Pract. 2013;7(5):e330–41.
   PubMed Web of Science ®Google Scholar
• Wu DT, Bitzer M, Ju W, et al. TGF-beta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes. J Am Soc Nephrol. 2005;16(11):3211–3221.
   PubMed Web of Science ®Google Scholar
• Grygielko ET, Martin WM, Tweed C, et al. Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis. J Pharmacol Exp Ther. 2005;313(3):943–951.
   PubMed Web of Science ®Google Scholar
• Nishida M, Okumura Y, Sato H, et al. Delayed inhibition of p38 mitogen-activated protein kinase ameliorates renal fibrosis in obstructive nephropathy. Nephrol Dial Transplant. 2008;23(8):2520–2524.
   PubMed Web of Science ®Google Scholar
• Jung DS, Li JJ, Kwak SJ, et al. FR167653 inhibits fibronectin expression and apoptosis in diabetic glomeruli and in high-glucose-stimulated mesangial cells. Am J Physiol Renal Physiol. 2008;295(2):F595–604.
   PubMed Web of Science ®Google Scholar
• Komatsu Y, Shibuya H, Takeda N, et al. Targeted disruption of the Tab1 gene causes embryonic lethality and defects in cardiovascular and lung morphogenesis. Mech Dev. 2002;119(2):239–249.
   PubMed Web of Science ®Google Scholar
• Stambe C, Nikolic-Paterson DJ, Hill PA, et al. Mitogen-activated protein kinase activation and cell localization in human glomerulonephritis: correlation with renal injury. J Am Soc Nephrol. 2004;15(2):326–336.
   PubMed Web of Science ®Google Scholar
• Omori E, Matsumoto K, Zhu S, et al. Ablation of TAK1 upregulates reactive oxygen species and selectively kills tumor cells. Cancer Res. 2010;70(21):8417–8425.
   PubMed Web of Science ®Google Scholar
• Ma FY, Tesch GH, Ozols E, et al. TGF-β1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney. Am J Physiol Renal Physiol. 2011;300(6):F1410–21.
   PubMed Web of Science ®Google Scholar
• Wu H, Zhou J, Ou W, et al. TAK1 as the mediator in the protective effect of propofol on renal interstitial fibrosis induced by ischemia/reperfusion injury. Eur J Pharmacol. 2017;811:134–140.
   PubMed Web of Science ®Google Scholar